Dr Alan Wise Duke St Bio

Dr. Alan Wise

Chief Executive Officer, Co-Founder

As CEO of Duke Street Bio, Alan brings to the role extensive leadership experience in the biotech and pharma sectors, across drug discovery and translational medicine.

Previously, Alan worked at IOmet Pharma from 2010, initially as Head of Biology, becoming CEO in 2015. Alan was instrumental in driving the successful sale of IOmet Pharma. Prior to joining IOmet, Alan, a biochemist by training, spent 12 years with GlaxoSmithKline, in a variety of program leadership roles spanning discovery and translation biology. He obtained his PhD in 1994 from the University of Leeds.

Management Team

Duke Street Bio has an experienced and proven management team with an exceptional track record of delivering clinical molecules across therapeutic areas.

Dr Alan Wise Duke St Bio

Peter Trill


Dr Phil Cowley Duke St Bio

Dr. Phill Cowley

Chief Scientific Officer

Barry McGuinness

Dr. Barry McGuinness

Chief Operating Officer

Delivering life-saving cancer treatments to improve patient outcomes.


2 Duke St. London